Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade
- PMID: 28789938
- DOI: 10.1016/j.bcp.2017.07.022
Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade
Abstract
Hyperglycemia up-regulates intracellular angiotensin II (ANG-II) production in cardiac myocytes. This study investigated the hemodynamic and metabolic effects of azilsartan (AZL) treatment in a mouse model of diabetic cardiomyopathy and whether the cardioprotective effects of AZL are mediated by the angiotensin converting enzyme (ACE)-2/ANG 1-7/Mas receptor (R) cascade. Control db/+ and db/db mice (n=5 per group) were treated with vehicle or AZL (1 or 3mg/kg/d oral gavage) from the age of 8 to 16weeks. Echocardiography was then performed and myocardial protein levels of ACE-2, Mas R, AT1R, AT2R, osteopontin, connective tissue growth factor (CTGF), atrial natriuretic peptide (ANP) and nitrotyrosine were measured by Western blotting. Oxidative DNA damage and inflammatory markers were assessed by immunofluorescence of 8-hydroxy-2'-deoxyguanosine (8-OHdG), tumor necrosis factor (TNF)-α and interleukin 6 (IL-6). Compared with db/+ mice, the vehicle-treated db/db mice developed obesity, hyperglycemia, hyperinsulinemia and diastolic dysfunction along with cardiac hypertrophy and fibrosis. AZL treatment lowered blood pressure, fasting blood glucose and reduced peak plasma glucose during an oral glucose tolerance test. AZL-3 treatment resulted in a significant decrease in the expression of cytokines, oxidative DNA damage and cardiac dysfunction. Moreover, AZL-3 treatment significantly abrogated the downregulation of ACE-2 and Mas R protein levels in db/db mice. Furthermore, AZL treatment significantly reduced cardiac fibrosis, hypertrophy and their marker molecules (osteopontin, CTGF, TGF-β1 and ANP). Short-term treatment with AZL-3 reversed abnormal cardiac structural remodeling and partially improved glucose metabolism in db/db mice by modulating the ACE-2/ANG 1-7/Mas R pathway.
Keywords: Angiotensin-II; Azilsartan; Azilsartan Pubmed CID: 9825285; Fibrosis; Hypertrophy; Inflammation; Oxidative stress.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.Free Radic Res. 2012 Jul;46(7):850-60. doi: 10.3109/10715762.2012.684878. Epub 2012 May 14. Free Radic Res. 2012. PMID: 22497476
-
Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.Life Sci. 2012 Feb 13;90(7-8):289-300. doi: 10.1016/j.lfs.2011.11.018. Epub 2011 Dec 19. Life Sci. 2012. PMID: 22210452
-
Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.Hypertens Res. 2014 Jul;37(7):616-20. doi: 10.1038/hr.2014.49. Epub 2014 Mar 6. Hypertens Res. 2014. PMID: 24599018
-
Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.Vasa. 2014 Nov;43(6):404-14. doi: 10.1024/0301-1526/a000387. Vasa. 2014. PMID: 25339158 Review.
-
The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.Curr Drug Targets. 2017;18(11):1301-1313. doi: 10.2174/1389450117666160727142401. Curr Drug Targets. 2017. PMID: 27469342 Review.
Cited by
-
Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.Clin Transl Immunology. 2018 Apr 18;7(4):e1016. doi: 10.1002/cti2.1016. eCollection 2018. Clin Transl Immunology. 2018. PMID: 29713471 Free PMC article. Review.
-
Berberine Reshapes the Balance of the Local Renin-Angiotensin System by Modulating Autophagy under Metabolic Stress in Pancreatic Islets.J Renin Angiotensin Aldosterone Syst. 2021 Aug 3;2021:9928986. doi: 10.1155/2021/9928986. eCollection 2021. J Renin Angiotensin Aldosterone Syst. 2021. PMID: 34394712 Free PMC article.
-
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).Int J Mol Med. 2021 Apr;47(4):43. doi: 10.3892/ijmm.2021.4876. Epub 2021 Feb 12. Int J Mol Med. 2021. PMID: 33576441 Free PMC article.
-
ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study.R Soc Open Sci. 2020 Nov 18;7(11):200958. doi: 10.1098/rsos.200958. eCollection 2020 Nov. R Soc Open Sci. 2020. PMID: 33391794 Free PMC article.
-
RAAS, ACE2 and COVID-19; a mechanistic review.Saudi J Biol Sci. 2021 Nov;28(11):6465-6470. doi: 10.1016/j.sjbs.2021.07.003. Epub 2021 Jul 10. Saudi J Biol Sci. 2021. PMID: 34305426 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous